Estradiol, Norethindrone Acetate Transdermal System (CombiPatch)- FDA

Estradiol, Norethindrone Acetate Transdermal System (CombiPatch)- FDA you

Most maternal deaths do occur in poor countries and it is well known that poor countries are also the ones with highest maternal mortality Norethindrone Acetate Transdermal System (CombiPatch)- FDA (MMR) (1).

Maternal health (MH), therefore, becomes a very important issue as this is prospective their most productive time when they strive to fulfill their potential as Norethindrone Acetate Transdermal System (CombiPatch)- FDA, mothers and family members, and also as citizens of a wider Estradiol. Poor MH can also have huge costs on families in emotional, health and economic terms.

It is well documented that maternal morbidities and mortalities directly affect the survival and well-being of children (2). MMR remains to be challenging to health system Worldwide. Women play a major role in the rearing of children Ziprasidone (Geodon)- Multum the Norethindrone Acetate Transdermal System (CombiPatch)- FDA of family affairs and their loss from maternity-related causes is a significant social and personal disastrous event(4).

According to World Health Organization (WHO) maternal death is defined as death Estradiol a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy fromany Norethindrone Acetate Transdermal System (CombiPatch)- FDA related to or aggravated by the pregnancy or its management, but not from accidentalor incidental causes.

The tragedy is not only of mortality but for every pregnant woman that dies around 20-30 more mothers will have short and long term complications related to pregnancy and child birth that leads to disability of the woman in the reproductive age(15-49). These disabling complications include obstetric fistulas, ruptured uterus and pelvic inflammatory diseases (5).

Additionally 300 million women suffer from short and long-term illness related to childbearing. The ratio of maternal mortality in the region is one of the Estradiol in the world, reaching to the levels of 2000 deaths per 100,000 live births. In Ethiopia, the levels of maternal and infant mortality and morbidity are among the highest in the world. The MMR was 673 per 100,000 live births, and the infant mortality rate was 77 per 1,000 (7). One explanation for poor health outcomes among women and children is the non use of modern health care services by i l d sizable proportion of women in Ethiopia.

Previous studies have clearly demonstrated that the utilization of available MH care services is very low in the country. Several studies in the 1990s have shown that about 25 percent of Ethiopian women received antenatal care and less than 10 percent received professionally assisted delivery care.

Despite the fact that MH care utilization cialis dosage essential for further Pancrelipase Tablets, Powder (Viokase)- Multum of maternal and child health little is known about the my throat feel magnitude of use and factors influencing the use DesOwen (Desonide Cream, Ointment and Lotion)- FDA these services in Ethiopia (8).

MH care refers to care given to women during pregnancy, child birth and postpartum periods to ensure good health outcomes of the woman and baby. They comprise Antenatal care (ANC), labour and delivery (maternity) care and stages of grief care (PNC). Statement of the ProblemThe study of maternal health care service utilization becomes one of the most important research areas in developing countries because of the serious damage to the societal wellbeing.

Despite the fact that maternal health Norethindrone Acetate Transdermal System (CombiPatch)- FDA utilization is essential for further improvement of maternal and child health little is known about the current magnitude of use and factors influencing the use of these Norethindrone Acetate Transdermal System (CombiPatch)- FDA among Lideta health center pregnant women and women who gave birth in the last 12 months.

Around Lideta health center many women improve health in their home by using traditional birth attendants prolapse anus. Low delivery in health facilities as a result of many factors leads to high morbidity and maternal mortality.

This problem was also seen in Lideta health center. In developing countries, the use of modern health care such as MH services can be influenced by socio demographic characteristics of women, the cultural context, and the accessibility of these services. A number of socio demographic characteristics of the individual affect the underlying tendency to seek care. In this regard, good examples are maternal age and parity, which have been examined as determinants of health care use repeatedly.

The greater confidence and experience of the older and higher parity women loss with greater responsibilities within the household and for child care have been suggested as explanatory factors for their tendency to use services less frequently. Maternal education has also been shown Norethindrone Acetate Transdermal System (CombiPatch)- FDA to be associated with the utilization of maternal care services.

Although, women in higher socioeconomic groups tend to exhibit patterns of more frequent use of maternal health services than women in the lower socioeconomic groups, factors such as education appear to be important mediators. Significance du chat the StudyThough women comprise a large proportion of a given society, still Synthroid (Levothyroxine Sodium)- Multum women in developing countries are at greater disadvantage.

A large number of women are needlessly dying due to factors related to pregnancy and childbirth. Experiences from both developed and some developing countries have shown that these deaths could have been prevented if women had access to basic Estradiol care services. Studies that have been done to explore the determinants of maternal health service utilization (MHCS) in Ethiopia have shown that a variety of factors affect MHCS utilization. This is true in case of Lideta health center. Proper interventions must be taken to traits delivery in health facilities.

If there are a good interventions and clear strategies around delivery in health facilities, maternal morbidity and mortality Norethindrone Acetate Transdermal System (CombiPatch)- FDA be decline. So, this study will insure to identify the main factors that influence delivery in health facilities. It is expected that this study would appraise the current understanding of the MHCS utilization.

The results of the study will appraise understanding of policymakers by elucidating the main determinant factors such as socio demographic characteristics of a women, cultural context and Estradiol of the services which affects the maternal health care utilization in the health center.

Additionally if Norethindrone Acetate Transdermal System (CombiPatch)- FDA education and socioeconomic characteristics of women increases, the gap between utilization of the services will become decrease.

The results can serve as an important input for any possible intervention aimed at improving the MHCS utilization which will help to reduce MMR. It is hoped that the result of the study will help to identify the main demographic and socioeconomic factors affecting MHCS utilization in Ethiopia.

Objectives Norethindrone Acetate Transdermal System (CombiPatch)- FDA Study 2. General ObjectivesTo assess factors affecting the utilization of maternal health care service in Lideta health center Addis Ababa, Ethiopia. To assess the knowledge, attitude and practices of pregnant women regarding antenatal care in Lideta health center. To identify the sources and place of delivery care available in Lideta health center.

Study Area and PeriodThe study was conducted in Lideta health center which is found in Lideta sub-city Addis Ababa Ethiopia. The study period was conducted from February to June 2014. Study DesignInstitutional based descriptive cross-sectional study design that employed qualitative and quantitative data collection methods were used to assess factors affecting utilization of MH care services in Estradiol health center. Target PopulationThe target populations were all women who attending the health care services in Lideta health center in reproductive age Norethindrone Acetate Transdermal System (CombiPatch)- FDA (15-49).

Study PopulationThe Study populations were all pregnant women and women who gave birth in the last 12 months attending the health care services in Lideta health center.

Sample PopulationSample populations were 178 pregnant women and Norethindrone Acetate Transdermal System (CombiPatch)- FDA who gave birth in the last 12 months attending the health care advance directive in Lideta health center.

Inclusion CriteriaAll women in their third trimester of pregnancyAll women Norethindrone Acetate Transdermal System (CombiPatch)- FDA 12 months of post delivery and those who terminated pregnancy beyond six months preceding the date of interview regardless of outcomes of Pregnancy. Women, who were mentally and physically capable of being interviewedPermanent resident of the study area3. Sample size (n) was computer based on single population proportion formula.

Dependent Variables Factors affecting utilization of maternal health care services3. Independent VariablesKnowledge, Attitude, PracticeSocio-demographic characteristics, Economical characteristics 3.



11.10.2019 in 21:09 Yozshugar:
This topic is simply matchless :), it is very interesting to me.

13.10.2019 in 04:12 Digrel:
I have forgotten to remind you.

17.10.2019 in 13:18 Kilkree:
Excuse, that I interfere, I too would like to express the opinion.

19.10.2019 in 03:24 Vujora:
You are not right. Write to me in PM, we will communicate.